Gene Expression of Promyelocytic Leukemia Proteins and IFN-γ Is Reduced in Rotavirus-Infected Children

Ahmed Jasim Mohammed1, Zeenah Weheed Atwan1, Aida Abdul-Kareem1

  • 1Department of Biology, College of Science, University of Basra, Basra, Iraq

Insights

Rotavirus infection significantly reduces the expression of antiviral proteins, including promyelocytic leukemia protein (PML) and its isoform PML-II, and interferon-gamma (IFN-γ). This suggests a potential role for these proteins in the host

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Rotavirus is a leading cause of gastroenteritis globally, necessitating research into host antiviral mechanisms.
  • Promyelocytic leukemia proteins (PMLs) are known for their antiviral functions, with PML isoform II (PML-II) specifically implicated.
  • Interferon-gamma (IFN-γ) plays a crucial role in the immune response against viral infections.

Purpose of the Study:

  • To investigate the gene expression levels of PML, PML-II, and IFN-γ in children with rotavirus gastroenteritis.
  • To determine the correlation between rotavirus infection and the expression of key antiviral and immune-related genes.

Main Methods:

  • Sample collection from 34 children under five with acute gastroenteritis and dehydration.
  • Rotavirus detection using PCR and Rapid Adeno/Rota Virus Antigen Combo Test.
  • Gene expression analysis of PML, PML-II, and IFN-γ via real-time PCR after RNA extraction and cDNA conversion.

Main Results:

  • Rotavirus was detected in 45% of stool samples by antigen test and 17.6% by PCR.
  • Significantly lower expression of PML (104-fold decrease), PML-II (13-fold decrease), and IFN-γ (104-fold decrease) was observed in rotavirus-positive samples compared to negative controls.

Conclusions:

  • Rotavirus infection is associated with a substantial downregulation of PML, PML-II, and IFN-γ gene expression.
  • These findings highlight a potential mechanism of viral evasion and underscore the importance of PML and IFN-γ in antiviral defense against rotavirus.
Abstract